{"id":7522,"date":"2026-10-23T08:23:03","date_gmt":"2026-10-23T02:53:03","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-23\/"},"modified":"2026-10-23T23:44:12","modified_gmt":"2026-10-23T18:14:12","slug":"sagility-share-price-today-2026-10-23","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-23\/","title":{"rendered":"Sagility Share Price Today: Why SAGILITY Is Falling 2.67% | 23 October 2026"},"content":{"rendered":"<style id=\"wt-article-style-v4\">:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) { color:#30475c; font-size:16px; line-height:1.65; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::before, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::after { box-sizing:border-box; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-copy { font-size:16px !important; line-height:1.65 !important; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-prose .wt-copy { margin-bottom:15px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-market-date { font-size:13px !important; line-height:1.55; color:#566b80; background:#f2f6f9; border:1px solid #dde6ec; border-left:4px solid #2e7db2; border-radius:6px; padding:8px 11px; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { display:grid; grid-template-columns:repeat(6,minmax(0,1fr)); gap:7px; margin:8px 0 16px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:10px !important; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:first-child { font-size:11px !important; line-height:1.45; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child { font-size:14px !important; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px 16px; min-width:0; overflow-wrap:anywhere; margin:14px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-title { font-size:16px; font-weight:800; line-height:1.45; color:#17324d; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-date { font-size:13px; line-height:1.5; color:#566b80; margin-bottom:9px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body { font-size:16px; line-height:1.6; color:#34495d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body .wt-copy:last-child { margin-bottom:0 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { display:grid; grid-template-columns:repeat(2,minmax(0,1fr)); gap:12px; margin:12px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > .wt-card { margin:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > :only-child { grid-column:1 \/ -1; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(3,minmax(0,1fr)); margin:10px 0 12px; gap:10px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-metric { background:#fff; border:1px solid #e1e8ef; border-radius:8px; padding:10px 12px; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-label { display:block; font-size:12px; font-weight:700; color:#566b80; line-height:1.5; margin-bottom:3px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-value { font-size:18px; font-weight:800; line-height:1.45; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-note { display:block; font-size:13px; color:#566b80; line-height:1.55; margin-top:4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source-note { margin:9px 0 4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source { display:inline-block; font-size:13px; line-height:1.5; margin-top:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { display:grid; grid-template-columns:2fr 1fr 1.2fr 1.2fr; gap:14px; padding:12px 0; border-bottom:1px solid #c9dbef; align-items:start; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row:last-of-type { border-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row strong { font-size:15px; line-height:1.5; display:block; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div { min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds { grid-template-columns:repeat(3,minmax(0,1fr)); margin:12px 0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card { padding:12px; background:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title { font-size:14px; font-weight:700; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:14px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-brokerage { grid-template-columns:1fr; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts { display:flex; flex-wrap:wrap; gap:14px 28px; margin:7px 0 12px; padding-bottom:10px; border-bottom:1px solid #cbd8ea; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts strong { font-size:16px; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list { font-size:16px !important; line-height:1.65; margin:0 0 12px; padding-left:20px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list li { margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card { background:#f7fbff !important; border-color:#cfe1f2 !important; border-left-color:#2e7db2 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card-title { color:#1f4d70; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-list { margin-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card { background:#f5fbfd !important; border-color:#c9d9e7 !important; border-left:5px solid #1f7b92 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-title { color:#174c5d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-body > strong { display:block; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:18px 19px; margin:22px 0; border-radius:13px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:19px; font-weight:800; line-height:1.4; margin-bottom:7px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow { background:linear-gradient(135deg,#ffe873,#ffd64a); border:1px solid #e3b600; box-shadow:0 8px 18px rgba(59,48,0,.09); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-title { color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-copy { color:#27364b !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark { background:#10233f; box-shadow:0 9px 22px rgba(16,35,63,.18); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-title { color:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-copy { color:#dce6f1 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-copy { font-size:16px !important; line-height:1.6; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-button { display:inline-block; background:#10233f; color:#fff !important; padding:10px 17px; border-radius:7px; text-decoration:none !important; font-size:15px; font-weight:800; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-button { background:#ffe36e; color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-faq h3 { color:#173b58 !important; font-size:17px !important; line-height:1.45; margin:18px 0 6px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) > p:last-child { font-size:13px; line-height:1.55; color:#606b78; border-top:1px solid #e1e7ef; padding-top:13px; margin-top:16px; }\n@media (max-width:960px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(3,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:1.7fr 1fr 1.2fr 1.2fr; gap:10px; }\n}\n@media (max-width:650px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { grid-template-columns:1fr; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(2,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:repeat(2,minmax(0,1fr)); gap:10px 14px; padding:12px 0; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-person, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div:last-child { grid-column:1 \/ -1; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:17px 15px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:18px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:9px !important; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:15px; }\n}\n@media (max-width:420px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(2,minmax(0,1fr)); }\n}<\/p>\n<p>:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div {border:1px solid #dde6ee;border-radius:8px;background:#f9fbfd;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child {font-weight:800;color:#17324d;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) h2 {font-size:24px !important;line-height:1.35 !important;margin:28px 0 14px !important;color:#173b58;}\n<\/style>\n<div class=\"wt-article-v4\" data-witty-phase=\"live\" data-article-version=\"4\">\n<p class=\"wt-market-date\"><strong>NSE: SAGILITY<\/strong> \u00b7 23 October 2026<\/p>\n<div class=\"wt-price-strip\">\n<div>\n<div>Price<\/div>\n<div>\u20b944.18<\/div>\n<\/div>\n<div>\n<div>Change<\/div>\n<div>-2.67%<\/div>\n<\/div>\n<div>\n<div>High \/ Low<\/div>\n<div>\u20b947.00 \/ \u20b943.39<\/div>\n<\/div>\n<div>\n<div>Prev. Close<\/div>\n<div>\u20b945.39<\/div>\n<\/div>\n<div>\n<div>Volume<\/div>\n<div>11.97 crore<\/div>\n<\/div>\n<div>\n<div>Price as of<\/div>\n<div>23 October 2026 \u00b7 03:30 PM IST<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-takeaways\">\n<div class=\"wt-card\" data-card=\"research\" style=\"background:#f4f8fd;border:1px solid #cbd8ea;border-left:4px solid #466fa5;border-radius:10px\">\n<div class=\"wt-card-title\">Key Takeaways<\/div>\n<div class=\"wt-card-body\">\n<ul class=\"wt-list\">\n<li>Sagility Limited (SAGILITY) moved lower during the trading session on October 23, 2026, closing down by 2.67% at \u20b944.18 compared to its previous close of \u20b945.39. The stock opened at \u20b946.58, touched an intraday high of \u20b947.00, and fell to a low of \u20b943.39.<\/li>\n<li>Sagility Limited issued a communication to shareholders regarding Tax Deduction at Source (TDS) provisions applicable to the interim dividend of \u20b90.15 per equity share for the financial year 2026-27. The interim dividend was declared by the Board of Directors at their meeting held on October 22, 2026, with the record date set for October 30, 2026. Shareholders are required to submit necessary tax exemption documents and update their bank details on the RTA web portal by November 3, 2026.<\/li>\n<li>Trading volume was 9.28 times the 20-day average daily volume.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<h2>Why is Sagility share price falling on 23 October 2026?<\/h2>\n<div class=\"wt-prose\">\n<p class=\"wt-copy\">Sagility Limited (SAGILITY) moved lower during the trading session on October 23, 2026, closing down by 2.67% at \u20b944.18 compared to its previous close of \u20b945.39. The stock opened at \u20b946.58, touched an intraday high of \u20b947.00, and fell to a low of \u20b943.39.<\/p>\n<p class=\"wt-copy\">The broader market and sector benchmarks also trended downwards, providing a negative macro backdrop. The Nifty index declined by 0.39%, while the sector benchmark Nifty Pharma dropped by 1.04%. Sagility&#x27;s decline of 2.67% underperformed both the headline index and the sector benchmark, reflecting stock-specific selling pressure despite its recent 2.21% gain in the prior trading session and 3.18% return over the past two sessions.<\/p>\n<p class=\"wt-copy\">The downward price movement coincided with ongoing disclosures regarding the company&#x27;s financial results and interim dividend announcements made on October 22, 2026, where the Board declared an interim dividend of \u20b90.15 per equity share with a record date of October 30, 2026. Additionally, the company recently announced its acquisition of Chirok Health to strengthen its provider segment and reported consolidated revenue of \u20b920,321 million for the quarter ended September 30, 2026. While these corporate developments outline active business growth and shareholder returns, today&#x27;s negative price action appears driven by immediate selling pressure and profit-taking following recent short-term gains.<\/p>\n<p class=\"wt-copy\">11.97 crore shares traded by 23 October 2026 \u00b7 03:30 PM IST. This compares with a 20-day average daily volume of 1.29 crore shares (9.28 times). The five-day average daily volume was 1.43 crore shares. Separately, the NSE report for 23 October 2026 showed 2.92 crore shares delivered, representing 24.38% of that day\u2019s traded volume. The same report recorded 173,786 trades.<\/p>\n<\/div>\n<div class=\"wt-likely-reason\">\n<div class=\"wt-card\" data-card=\"research\" style=\"background:#f4f8fd;border:1px solid #cbd8ea;border-left:4px solid #466fa5;border-radius:10px\">\n<div class=\"wt-card-title\">Likely Reason<\/div>\n<div class=\"wt-card-body\"><strong>profit-taking after recent gains amid sector weakness<\/strong><\/p>\n<p class=\"wt-copy\">Sagility&#x27;s 2.67% decline occurred alongside broader sector underperformance in Nifty Pharma (-1.04%) and the Nifty index (-0.39%), following recent positive momentum where the stock posted gains over the prior two sessions. High cash volume participation at over 9 times the 20-day average indicates active institutional or trader rotation rather than a single negative news trigger.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Latest Company Developments<\/h2>\n<div class=\"wt-grid wt-grid-news\">\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Interim Dividend and Tax Deduction Communication<\/div>\n<div class=\"wt-card-date\">23 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Sagility Limited issued a communication to shareholders regarding Tax Deduction at Source (TDS) provisions applicable to the interim dividend of \u20b90.15 per equity share for the financial year 2026-27. The interim dividend was declared by the Board of Directors at their meeting held on October 22, 2026, with the record date set for October 30, 2026. Shareholders are required to submit necessary tax exemption documents and update their bank details on the RTA web portal by November 3, 2026.<\/p>\n<p class=\"wt-copy\">Informs shareholders of record about tax compliance and procedural requirements for receiving the interim dividend payout scheduled for on or before November 21, 2026.<\/p>\n<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Strong Q2 FY27 Financial Results and Interim Dividend<\/div>\n<div class=\"wt-card-date\">22 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">The company reported consolidated financial results for the quarter ended September 30, 2026, posting revenue of \u20b920,321 million, marking a 22.5% year-on-year growth. Adjusted EBITDA came in at \u20b95,353 million at 26.3% of revenue, while Adjusted PAT stood at \u20b93,254 million. Alongside the results, the Board declared an interim dividend of \u20b90.15 per share for FY2026-27.<\/p>\n<p class=\"wt-copy\">Provides a comprehensive view of the company&#x27;s operating performance, profitability margins, and cash generation capability entering the second half of the fiscal year.<\/p>\n<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Acquisition of Chirok Health to Accelerate Provider Growth<\/div>\n<div class=\"wt-card-date\">21 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Sagility announced the acquisition of Chirok Health LLC to accelerate its provider growth strategy. The transaction adds specialized clinical documentation improvement (CDI) and coding capabilities, extending the company&#x27;s end-to-end revenue cycle management (RCM) offering.<\/p>\n<p class=\"wt-copy\">Expands the company&#x27;s service capabilities within the healthcare provider segment and unlocks new market opportunities for its technology-enabled solutions.<\/p>\n<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Record Date<\/div>\n<div class=\"wt-card-date\">23 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">SAGILITY LIMITED has informed the Exchange that Record date for the purpose of Interim Dividend is 30-Oct-2026.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026185240_IntimationRecordDateSigned.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Sagility shares fall 4% despite 22% revenue growth in Q2: Should you buy, sell or hold? &#8211; Moneycontrol.com<\/div>\n<div class=\"wt-card-date\">23 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Sagility shares fall 4% despite 22% revenue growth in Q2: Should you buy, sell or hold? Moneycontrol.com<\/p>\n<\/div>\n<\/div>\n<\/div>\n<h2>Ownership &amp; Transaction Activity<\/h2>\n<div class=\"wt-grid wt-grid-ownership\">\n<div class=\"wt-card\" data-card=\"ownership\" style=\"background:#fff8e8;border:1px solid #ecd39e;border-left:4px solid #cc922c;border-radius:10px\">\n<div class=\"wt-card-title\">Shareholding<\/div>\n<div class=\"wt-card-date\">As of 30 September 2026<\/div>\n<div class=\"wt-card-body\">\n<div class=\"wt-grid wt-grid-metrics\">\n<div class=\"wt-metric\">\n<div class=\"wt-label\">Promoter holding<\/div>\n<div class=\"wt-value\">50.95%<\/div>\n<div class=\"wt-note\">50.95% on 30 June 2026<\/div>\n<\/div>\n<div class=\"wt-metric\">\n<div class=\"wt-label\">FII\/FPI<\/div>\n<div class=\"wt-value\">10.38%<\/div>\n<div class=\"wt-note\">9.99% on 30 June 2026<\/div>\n<\/div>\n<div class=\"wt-metric\">\n<div class=\"wt-label\">Institutional holding<\/div>\n<div class=\"wt-value\">32.97%<\/div>\n<div class=\"wt-note\">31.41% on 30 June 2026<\/div>\n<\/div>\n<\/div>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1737173_13102026055925_WEB.xml\" rel=\"noopener\">NSE shareholding filing \u2192<\/a><\/div>\n<\/div>\n<\/div>\n<h2>Mutual Fund Holdings<\/h2>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Mutual-fund ownership<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Mutual funds held 15.13% on 30 September 2026. This compares with 13.45% on 30 June 2026, a change of +1.68 percentage points.<\/p>\n<p class=\"wt-copy\">The filing reported 33 MF\/UTI holders.<\/p>\n<div class=\"wt-grid wt-grid-funds\">\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">ICICI Prudential Technology Fund<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">15.88 crore shares \u00b7 3.39%<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Kotak Small Cap Fund<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">8.70 crore shares \u00b7 1.86%<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Canara Robeco Mutual Fund A\/C Canara Robeco Small Cap Fund<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">8.33 crore shares \u00b7 1.78%<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-note wt-source-note\">These are quarterly holdings, rather than purchases or sales on the article date.<\/div>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1737173_13102026055925_WEB.xml\" rel=\"noopener\">NSE shareholding filing \u2192<\/a><\/div>\n<\/div>\n<h2>What to Watch Next<\/h2>\n<ul class=\"wt-list\">\n<li>Execution and financial impact of the newly acquired Chirok Health and CareSeed integration.<\/li>\n<li>Shareholder response and processing of interim dividend tax documentation ahead of the October 30, 2026 record date.<\/li>\n<li>Operational performance during the seasonally stronger second half of fiscal year 2027.<\/li>\n<li>Delivery volume trends relative to the 20-day average volume of ~12.9 million shares.<\/li>\n<\/ul>\n<h2>Other Dated Coverage<\/h2>\n<ul class=\"wt-list\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-22\/\">Sagility Share Price Today: Why SAGILITY Is Rising 2.21% | 22 October 2026 \u2014 22 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-19\/\">Sagility Share Price Today: Why SAGILITY Is Falling 2.89% | 19 October 2026 \u2014 19 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-06\/\">Why Sagility Shares Are Rising 3.08% Today | 6 October 2026 \u2014 6 October 2026<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/tag\/sagility\/\">More Sagility news and dated analysis \u2192<\/a><\/p>\n<aside class=\"wt-cta wt-cta-dark\">\n<div class=\"wt-cta-title\">Looking for Research-Backed Market Opportunities?<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Frequently Asked Questions<\/h2>\n<div class=\"wt-faq\">\n<h3>What is the latest Sagility company news?<\/h3>\n<p class=\"wt-copy\">Sagility Limited issued a communication to shareholders regarding Tax Deduction at Source (TDS) provisions applicable to the interim dividend of \u20b90.15 per equity share for the financial year 2026-27. The interim dividend was declared by the Board of Directors at their meeting held on October 22, 2026, with the record date set for October 30, 2026. Shareholders are required to submit necessary tax exemption documents and update their bank details on the RTA web portal by November 3, 2026.<\/p>\n<h3>How strong was Sagility\u2019s trading volume?<\/h3>\n<p class=\"wt-copy\">11.97 crore shares traded, 9.28 times the 20-day average daily volume. The price and volume data are dated 23 October 2026 \u00b7 03:30 PM IST.<\/p>\n<h3>Do the mutual-fund figures show buying today?<\/h3>\n<p class=\"wt-copy\">They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.<\/p>\n<\/div>\n<p><strong>Research &amp; analysis:<\/strong> <a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">WittyTrades Research Desk<\/a><br \/><strong>Reviewed by:<\/strong> <a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">Mohanish Sanghavi \u2014 SEBI Registered Research Analyst<\/a><\/p>\n<p>Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.<\/p>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-23\/#article\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-23\/\"}, \"headline\": \"Sagility Share Price Today: Why SAGILITY Is Falling 2.67% | 23 October 2026\", \"description\": \"Sagility share price fell 2.67% to \u20b944.18 today. See why SAGILITY is falling, volume context, company developments and what to watch next.\", \"datePublished\": \"2026-10-23T02:53:03Z\", \"dateModified\": \"2026-10-23T23:44:04.788292+05:30\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"reviewedBy\": {\"@type\": \"Person\", \"name\": \"Mohanish Sanghavi\", \"jobTitle\": \"SEBI Registered Research Analyst\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"inLanguage\": \"en-IN\", \"image\": [\"https:\/\/www.wittytrades.com\/market-news\/wp-content\/uploads\/2026\/10\/sagility-company-news-2026-10-23.jpg\"]}<\/script><!-- wt-article-record:{\"news_events\":[{\"title\":\"Updates\",\"summary\":\"'Communication to Shareholders regarding TDS on Interim Dividend FY2026-27'.\",\"source\":\"NSE\",\"published\":\"23-Oct-2026 18:23:44\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_23102026182338_IntimationTDSCommunicationsigned.pdf\",\"disclosure_text\":\"Date: October 23, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C\/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir\/Ma\u2019am, Subject: Communication to Shareholders Regarding TDS on Interim Dividend FY 2026-27. This is to inform you that, following the declaration of interim dividend for the financial year 2026\u201327 by the Board of Directors at its meeting held on October 2 2, 2026, the Company has sent the attached email communication to shareholders whose email addresses are registered with the Depositories\/Company. The communication relates to tax provisions applicable to the dividend payment. A specimen of the said communication is enclosed herewith for your reference and records. The above information is being made available on the website of the Company https:\/\/sagility.com\/ Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No. A16008 Encl: a\/a Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 23, 2026 Subject: Tax Deduction at Source (\u201cTDS\u201d) on Interim Dividend for the Financial Year 2026-27 Dear Member, We are pleased to inform you that the Board of Directors of Sagility Limited (\u201cthe Company\u201d), at its meeting held on October 22, 2026, has declared an interim dividend of Rs. 0.15 per equity share of face value of Rs. 10 each for the Financial Year 2026 -27. The said interim dividend will be payable to those shareholders whose names appear in the Register of Members of the Company or in the records of the Depositories, in electronic form, as beneficial owners of the equity shares of the Company, as on the record date, i.e. Friday, October 30, 2026. This communication provides a brief of the applicable TDS provisions under the Income-tax Act, 2025 (\u201cthe Act\u201d) for Resident and Non-Resident Shareholder categories. As per the Act, dividend paid or distributed by a company is taxable in the hands of shareholders. Therefore, the Company is required to deduct taxes at source at the rates applicable on the amount distributed to the shareholders. Accordingly, shareholders holding shares in dematerialized mode, are requested to update their records such as tax residential status as per the Act, Permanent Account Number (\u201cPAN\u201d), category, residential address and register their email addresses, mobile numbers and other details with their relevant depositories through their Depository Participants (\u201cDP\u201d) or with the Registrar and Share Transfer Agent of the Company - MUFG Intime India Private Limited (\u201cRTA\u201d). The tax rates for deduction would vary depending on residential status of shareholders, category of shareholders, and exemptions as provided in the Act subject to submission of certain particulars\/ forms\/ documents as mentioned below. A. Resident Shareholders (both Individuals and Non-Individuals) Tax will be deducted at source under Section 393(1) (Table: Sl. No. 7) of the Act at the rate of 10% on the amount of dividend payable unless exempt under any of the provisions of the Act, subject to fulfilment of the following conditions: (a) Valid PAN is registered with DP or RTA. In case PAN is not available or PAN is invalid, TDS would be done at higher rate of 20%. (b) As per Section 262(6)(a) of the Act read with Rule 162 of the Income-tax Rules, 2026 (\u201cthe Rules\u201d), every person who has been allotted a PAN and who is eligible to obtain Aadhaar (unless specifically exempted), shall be required to link the PAN with Aadhaar. In case of failure to comply with this, the PAN allotted shall be deemed to be invalid\/ inoperative and shall be liable to all consequences under the Act. Tax shall be deducted at a higher rate, as provided in Section 397(2) of the Act, i.e., 20% ( for determining TDS rate, the Company may use and rely on the compliance check utility issued by the Income Tax Department to determine the validity of PANs and inoperative PANs and any such determination shall be final). Provided that tax will not be deducted from payment to resident individual shareholders, if the aggregate of total dividend paid\/ payable to them by the Company during tax year 2026- 27 does not exceed Rs.10,000. Apart from the above, specific provisions applicable to Resident Shareholders are given below for ready reference. Particulars of resident shareholders Applicable rate of TDS Documents required, if any Resident Individual Shareholders with valid Form 121 Nil No TDS shall be done if duly signed Form 121 is submitted to the Company along with self -attested copy of PAN card, provided that the form is accurately filled, and it meets the prescribed eligibility conditions. Fillable PDF Format of Form 121 is available at the link provided below. Please note all fields are mandatory to be filled up and the Company may at its sole discretion reject the form if it does not fulfil the requirements of the Act and the Rules made thereunder. Life Insurance Corporation (\u201cLIC\u201d), General Insurance Company (\u201cGIC\u201d), Other Insurer Nil As per the provisions of section 393(4) (Table: Sl. No. 10) of the Act, no tax is required to be deducted on dividend paid to LIC, GIC or its subsidiaries, or any other insurer in respect of shares owned by them or in which they have full beneficial interest. Self-declaration qualifying for exemption stating that the shareholder is the owner Particulars of resident shareholders Applicable rate of TDS Documents required, if any or has full beneficial interest with respect to shares along with self-attested copy of PAN card and valid self -attested IRDAI registration certificate needs to be submitted. Shareholders covered under Section 393(5) of the Act [i.e. Mutual fund as specified at Schedule VII (Table: Sl. No. 20 or 21), Government, etc.] Nil As per the provisions of section 393(5) of the Act, no tax is required to be deducted on dividend paid to specific entities including Mutual Fund specified at Schedule VII (Table: Sl. No. 20 or 21). Self-declaration by Mutual Fund shareholder specified at Schedule VII (Table: Sl. No. 20 or 21) of the Act stating that the shareholder is eligible for exemption along with self -attested copy PAN card and valid self -attested copy of SEBI registration certificate\/any other documentary evidence that person is covered under provision of Section 393(5) of the Act needs to be submitted. Category I and II Alternative Investment Fund (AIF) established \/ incorporated in India covered by Notification no. 51\/2015 dated June 25, 2015 Nil No TDS is required to be done as per the exemption provided in Schedule V (Table: Sl. No. 1) of the Act, subject to specified conditions. Self-declaration that the shareholder is eligible for exemption under Schedule V (Table: Sl. No. 1) of the Act and established as Category I or Category II AIF under SEBI regulations, along with self-attested copies of registration certificate and documents issued by SEBI and PAN card needs to be submitted. Shareholders whose income is unconditionally exempt (e.g. entities covered by the CBDT circular No. 18\/2017 dated 29 th May,2017) Nil Self-declaration stating that the shareholder is - - unconditionally exempt under the relevant provision of the Act. - Is covered by CBDT circular No. 18\/2017 dated 29 th May,2017 under the relevant notification\/ circular. Particulars of resident shareholders Applicable rate of TDS Documents required, if any - has full beneficial interest in shares owned by it. - along with self -attested copy of applicable registration certificate and self-attested copy of PAN card. Any other documents as prescribed under the Act for lower\/Nil deduction of taxes Rate provided in the lower or nil withholding tax Order or Nil in case of valid exemption through circular\/notification 1. Lower\/ Nil withholding tax certificate obtained from tax authority for the Tax Year 2026-27. 2. Shareholders who are exempted from TDS provisions through any circular or notification may provide documentary evidence in relation to the same, to enable the Company in applying the appropriate TDS on dividend payments to such shareholder. B. Non-Resident shareholders Tax will be deducted at source under section 393(2) of the Act at the applicable rates on the amount of dividend payable unless exempt under any of the provisions of the Act subject to fulfilment of the conditions as mentioned in the Act. The table below shows the applicable rates for TDS: Particulars of non- resident shareholders Applicable rate Documents required, if any Non-resident shareholders (including Foreign Institutional Investors and Foreign Portfolio Investors) 20% (plus applicable surcharge and cess) OR DTAA Rate* (whichever is lower) In order to avail the benefit of Double Taxation Avoidance Agreement (\u201cDTAA\u201d), the following documents are required to be submitted to the Company: 1. Self-attested copy of Indian PAN card. In case PAN is not available, a declaration to this effect. 2. Copy of Tax Residency Certificate (TRC) for the FY 2026 -27 issued by the tax revenue department of your home country, duly attested by shareholders\/ authorized signatory. 3. Form 41 for FY 2026 -27 as per the Rule 75 of the Rules filed electronically on the Indian Income Tax Portal**. 4. Self-declaration from non -resident, primarily covering the following (draft declaration is available at the link below): Particulars of non- resident shareholders Applicable rate Documents required, if any \u2022 Non-resident is and will continue to remain a tax resident of the country of its residence during the Financial Year 2026-27. \u2022 Non-resident is eligible to claim the benefit of respective DTAA. \u2022 Non-resident receiving the dividend income is the beneficial owner of such income. \u2022 Dividend income is not attributable\/effectively connected to any Permanent Establishment (PE) or Fixed Base in India. \u2022 Non-resident does not have a place of effective management in India and is not prohibited by the provisions of General Anti Avoidance Rules (\u201cGAAR\u201d) for taking benefit under the DTAA. \u2022 Non-resident satisfies the Principal Purpose Test, Simplified Limitation of Benefit test (if applicable), any other criteria as may be applicable as regards the eligibility to claim recourse to concerned DTAA. 5. In case of Foreign Institutional Investors and Foreign Portfolio Investors, self -attested copy of SEBI registration certificate. Non-resident shareholder having order under section 395 of the Act*** (i.e. lower or Nil withholding tax certificate) Rate provided in the certificate Lower\/Nil withholding tax certificate obtained from tax authority. * The Company is not obligated to apply the beneficial DTAA rates at the time of tax deduction\/withholding on dividend amounts. Application of beneficial DTAA rate shall depend upon the completeness of all the above-mentioned documents submitted by the non-resident shareholder and review to the satisfaction of the Company. It is recommended that shareholders independently satisfy their eligibility to claim DTAA benefit including meeting of all conditions laid down by DTAA. ** Shareholders would need to login into the Income Tax Portal and file Form 41 online and share the final copy with the Company\/RTA. *** Withholding rate lower than the rates prescribed in the Act or the relevant DTAA shall be applied only on submission of a valid lower\/nil withholding certificate under Section 395 of the Act obtained from the tax authority. Shareholders having multiple accounts under different status\/category: Shareholders holding shares of the Company under multiple accounts, under different status\/ category and single PAN, may note that higher rate of tax, as applicable to the status in which shares are held under the PAN, will be considered on their entire holding in different accounts. Declaration under Rule 203: In terms of Rule 203 of the Rules, if dividend income on which tax has been deducted at source is assessable in the hands of a person other than the deductee on the Record date, then the deductee should file signed declaration with the Company on the letterhead containing the name, address, PAN, residential status\/category of the person to whom TDS credit is to be given and reasons for giving credit to such person in the manner prescribed in the Rules. The draft format of the declaration is attached herewith. General Instructions: In order to enable the Company to determine and deduct appropriate TDS\/ withholding tax, shareholders are requested to submit required forms and documents for Financial Year 2026- 27, for the purpose of claiming exemption from tax deduction (duly completed and signed) on RTA\u2019s website at https:\/\/web.in.mpms.mufg.com\/formsreg\/submission-of-Form-121- 41.html on or before the close of business hours on November 03, 2026. No communication would be accepted from shareholders after the date mentioned above, in relation to tax determination\/ deduction matters. Further, with regard to Rule 203 of the Rules for request to pass on credit to person other than registered shareholders, no communication shall be entertained on or after November 13, 2026. The aforementioned forms for tax exemption can be downloaded from URL mentioned below. Form 121: Click here Self-Declaration for Mutual Funds: Click here Self-Declaration for Insurance Companies: Click here Self-Declaration for Alternative Investment Fund: Click here Self-declaration for other resident non-individual Shareholders: Click here Self-Declaration under Rule 203: Click here Self-Declaration for non-resident Shareholders: Click here Kindly note that any forms, declarations and documents that are incomplete and\/or unsigned will not be considered by the Company. Once user clicks on the above link, this page shall prompt the shareholder to select \/ share the following information to register their request: 1. Select the company (Dropdown - Sagility Limited) 2. Folio \/ DP-Client ID 3. PAN 4. Financial year (Dropdown) 5. Form selection 6. Document attachment \u2013 1 (PAN) 7. Document attachment \u2013 2 (Forms) 8. Document attachment \u2013 3 (Any other supporting document) Further, please note that all forms\/declarations submitted are valid for one Financial Year, i.e. FY 2026-27. Please note that documents uploaded on the above web -portal will only be considered for computation of TDS. Shareholders may also note that any other method of submission of documents will not be considered valid for tax determination\/tax deduction matters. Further, if the tax on said Dividend is deducted at a higher rate in absence of receipt of or satisfactory completeness of the aforementioned details\/documents by the Company, the shareholder may claim an appropriate refund in the return of income filed with their respective Tax authorities. No claim shall lie against the Company for such taxes deducted. For all self-attested documents, shareholders must mention on the document \u201ccertified true copy of the original\u201d. For all documents being uploaded by the shareholder, the shareholder undertakes to send the original document(s) upon request by the Company. In case of joint shareholders, the shareholder named first in the Register of Members\/list of Beneficial Owners are required to furnish the requisite documents for claiming any applicable beneficial tax rate. In the event of any income tax demand (including interest, penalty, etc.) arising from any misrepresentation, inaccuracy or omission of information provided \/ to be provided by the shareholder(s), such shareholder(s) will be responsible to indemnify the Company and also, provide the Company with all information\/ documents and co-operation in any tax\/ appellate proceedings. Further, shareholders who have not registered their email address are requested to provide DPID-CLID (16 digit DPID + CLID or 16-digit beneficiary ID), Name, client master or copy of Consolidated Account statement, PAN (self-attested scanned copy of PAN card), AADHAR (self-attested scanned copy of Aadhar Card) to your DP. The Company will arrange to email a soft copy of TDS certificate to you at your registered email ID post completion of activities as per the prescribed timelines. Shareholders will also be able to see the credit of TDS in Form 168 after January 31, 2027, which can be downloaded from their e-filing account at Income Tax Portal, Government of India Login Page or by logging with their credentials at \u2018TRACES\u2019 account on TDS Reconciliation Analysis and Correction Enabling System. UPDATION OF BANK ACCOUNT DETAILS While on the subject, shareholders are requested to ensure that their bank account details (IFSC Code, MICR, etc.) in their respective demat accounts (with the DP)\/ physical folios (with the RTA in Form ISR-1) are updated, to enable the Company to make timely credit of dividend in their bank accounts. Disclaimer: Above communication on TDS sets out the provisions of law in a summary manner only and does not purport to be a complete analysis or listing of all potential tax consequences. Should you seek any further clarification, please write to us at investor.helpdesk@in.mpms.mufg.com OR dividend.tax@sagility.com & dividend.tax@sagilityhealth.com. This Comm\"},{\"title\":\"Record Date\",\"summary\":\"SAGILITY LIMITED has informed the Exchange that Record date for the purpose of Interim Dividend is 30-Oct-2026.\",\"source\":\"NSE\",\"published\":\"22-Oct-2026 18:53:02\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026185240_IntimationRecordDateSigned.pdf\",\"disclosure_text\":\"Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 22, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C\/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir\/Ma\u2019am, Sub: Record Date for Interim Dividend. Ref.: Regulatio ns 42 of SEB I (Listin g Obligations and Disclosure Requirements) Regulations, 2015 This is to inform you that, pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors, at its meeting held on Thursday, October 22, 2026, has fixed Friday, October 30, 2026, as the record date for determining the eligibility of shareholders for payment of interim dividend for the financial year 2026\u201327. The interim dividend shall be paid on or before November 21, 2026. Symbol\/ Scrip Code Type of Security Record Date Purpose SAGILITY (NSE) 544282 (BSE) Equity Shares Friday, October 30, 2026 Payment of Interim Dividend of Rs. 0.15\/- per share (face value of Rs. 10\/- each) for FY2026-27 You are requested to kindly take the above information on record. The above information is being made available on the website of the Company https:\/\/sagility.com\/ Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No. A16008\"},{\"title\":\"Sagility shares fall 4% despite 22% revenue growth in Q2: Should you buy, sell or hold? - Moneycontrol.com\",\"summary\":\"Sagility shares fall 4% despite 22% revenue growth in Q2: Should you buy, sell or hold? Moneycontrol.com\",\"source\":\"Moneycontrol.com\",\"published\":\"Fri, 23 Oct 2026 08:16:53 GMT\",\"source_type\":\"business media\",\"generic_watchlist\":false},{\"title\":\"Dividend\",\"summary\":\"SAGILITY LIMITED has informed the Exchange that Board of Directors at its meeting held on October 22, 2026, declared Interim Dividend of Rs. 0.15 per equity share.\",\"source\":\"NSE\",\"published\":\"22-Oct-2026 18:48:18\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026184806_IntimationDividendSigned.pdf\",\"disclosure_text\":\"Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 22, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C\/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir\/Ma\u2019am, Sub: Declaration of Interim Dividend for the financial year 2026-27. Ref.: Regulations 30 read with Schedule III & Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform you that the Board of Directors of the Company, at its meeting held today, i.e., Thursday, October 22, 2026, has declared an interim dividend of \u20b9 0.15 per equity share of face value \u20b910 each for the financial year 2026\u201327. The dividend shall be payable to those members whose names appear as beneficial owners in the records of the Depositories as on the Record Date, i.e., October 30, 2026. The interim dividend will be paid on or before November 21, 2026. The meeting commenced at 5:00 p.m. (IST) and concluded at 5:40 p.m. (IST). You are requested to kindly take the above information on record. The above information is being made available on the website of the Company https:\/\/sagility.com\/ Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No. A16008\"},{\"title\":\"Press Release\",\"summary\":\"a press release dated October 22, 2026, titled \\\"Press release pertaining to unaudited financial results (standalone & consolidated) for the quarter ended September 30, 2026\\\".\",\"source\":\"NSE\",\"published\":\"22-Oct-2026 18:44:34\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026184424_IntimationPressReleaseSigned.pdf\",\"disclosure_text\":\"Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 22, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C\/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir\/Ma\u2019am, Subject: Press Release pertaining to the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. With reference to the captioned subject, please find enclosed the press release issued by Sagility Limited pertaining to the unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30, 2026. This is for your kind information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No. A16008 Encl: a\/a Sagility Ltd. Press Release 1 Performance Review of Q2 FY27 & H1 FY27 Strong Q2 performance with Revenue growth of 22.5% YoY (12.2% in constant currency) Adjusted EBITDA at 26.3% with 23.0% growth YoY Adjusted PAT at 16.0% with 8.1% growth YoY Bengaluru, India | Oct 22, 2026: Sagility Limited (NSE: SAGILITY, BSE: 544282), a leading global healthcare operations partner that helps U.S. payers, providers, and pharmacy benefit managers reduce costs, improve quality, and enhance member and provider experiences, reported its consolidated financial results for the quarter Q2 FY27 ended September 30, 2026, according to IndAS. Financial highlights for the quarter ended Sep 30, 2026: \u2022 Revenue at \u20b9 20,321 million (US$ 212.6 million), YoY growth of 22.5% (12.2% in CC terms) \u2022 Organic YoY growth of 22.2% (11.9% in CC terms) \u2022 Adjusted EBITDA at \u20b9 5,353 million (US$ 56.0 million) at 26.3% of revenue, YoY growth of 23.0% \u2022 Adjusted PAT at \u20b9 3,254 million (US$ 34.0 million) at 16.0% of revenue, YoY growth of 8.1% \u2022 Basic Earnings per share (EPS) at \u20b9 0.61, YoY growth of 13.3% \u2022 Adjusted Basic Earnings per share (EPS) at \u20b9 0.70, YoY growth of 8.1% Financial highlights for the half year ended Sep 30, 2026: \u2022 Revenue at \u20b9 39,956 million (US$ 420.4 million), YoY growth of 25.0% (13.7% in CC terms) \u2022 Organic YoY growth of 24.7% (13.4% in CC terms) \u2022 Adjusted EBITDA at \u20b9 10,069 million (US$ 105.9 million) at 25.2% of revenue, YoY growth of 25.2% \u2022 Adjusted PAT at \u20b9 5,951 million (US$ 62.6 million) at 14.9% of revenue, YoY growth of 18.9% \u2022 Basic Earnings per share (EPS) at \u20b9 1.07, YoY growth of 25.4% \u2022 Adjusted Basic Earnings per share (EPS) at \u20b9 1.27, YoY growth of 18.9% Business Highlights: \u2022 Sagility secured $40.2 million of ACV from 31 existing clients and 1 new logo. \u2022 Added 28 client groups in H1 FY27 (including clients acquired through the CareSeed acquisition), bringing the total active client group base to 105. \u2022 Growing AI momentum with new SOW wins, with more production deployments, and AI-led GTM enabling faster solutioning \u2022 Acquired Chirok Health LLC to accelerate Provider segment growth. The acquisition adds specialized CDI and coding capabilities, extending Sagility\u2019s end -to-end RCM offering and unlocking new growth opportunities. \u2022 Employees: At the end of Q2, Sagility had 51,486 employees \u2022 Geo Presence: As of Sep 30, 2026, Sagility had a presence in 5 countries with 28 delivery centers \u2022 Interim Dividend of \u20b9 0.15 per share Sagility Ltd. Press Release 2 Rewards & Recognitions: \u2022 Sagility is recognized as Leader in Avasant\u2019s Healthcare Payer Business Process Transformation 2026 RadarView\u2122 \u2022 Sagility\u2019s SmarTec Nurse Assist solution won 2026 Stratus Awards for Cloud Computing by Business Intelligence Group in SaaS category \u2022 Received the Voice of the Customer Honor \u2013 HLS Services Specialist \u2022 Sagility India ranked 57th among the 100 Best Large Workplaces in Asia 2026 by Great Place to Work\u00ae and was also recognized among the Top 10 India\u2019s Best Workplaces for Women 2026. \u2022 Sagility India Earns Great Place To Work\u00ae Certification\u2122 for the second consecutive year \u2022 Winner of Bronze Stevie\u00ae Award in the AI Adoption with Headcount Growth \u2022 Sagility won the Golden Peacock Award for ESG Commenting on the results announcement, Ramesh Gopalan, Managing Director and Group CEO said, \u201cOur performance in the first half of FY27 reflects broad-based momentum across the business. Our pipeline is healthy with larger deals and a growing set of opportunities with Blues and mid-market plans. Our AI solutions are gaining traction, with new SOW wins and more solutions moving into production. CareSeed is now integrated into our Clinical Practice, adding depth to our healthcare quality capabilities and our recent acquisition of Chirok will accelerate our growth in the provider segment, strengthening our end-to-end provider RCM capabilities. As we enter the second half, our priority is disciplined execution through the AEP and Open Enrolment season, while investing in the capabilities that will drive our next phase of growth.\u201d Srinivas Mattapalli, Group Chief Financial Officer added, \u201cQ2 FY27 was a strong quarter with healthy growth, robust cash generation and our highest adjusted EBITDA margin in six quarters, reflecting disciplined execution, operating leverage and delivery efficiencies. Our revenue trajectory demonstrates the resilience of the operating model as we enter the seasonally stronger H2. Underscoring our confidence in the business and our commitment to shareholder returns , the Board has declared an interim dividend of \u20b90.15 per share, up from \u20b90.05 in the previous interim. We will continue to invest selectively in technology, AI and domain -led growth to create long- term value for our stakeholders.\u201d About Sagility Limited Sagility is a leading healthcare operations partner that helps payers, providers, and pharmacy benefit managers reduce costs, improve quality, and enhance member and provider experiences. With more than 25 years of exclusive focus in healthcare, Sagility combines deep domain expertise with technology -led transformation - embedding analytics, automation, and AI directly into operations while ensuring compliance with complex regulatory and clinical requirements. Serving over 100 healthcare clients, including 7 of the top U.S. health plans, Sagility delivers end -to-end operational transformation at scale through a model built on accountability, transparency, and measurable outcomes. To learn more, visit: https:\/\/sagility.com\/ Safe Harbour Certain statements in this release concerning our future growth prospects may be seen as forward -looking statements, which involve a number of risks and uncertainties that could cause the actual results to differ materially from such statements. The Company does not undertake to update any forward-looking statement that may be made from time to time, except as required by applicable law. Contact Investor Relations Media Contact Abhishek Kayan abhishek.kayan@sagility.com Srushti Rao press@sagility.com Sagility Ltd. Press Release 3 KPIs Quarter KPIs Q2 FY27 Q1 FY27 Q2 FY26 Y-o-Y % H1 FY27 H1 FY26 Y-o-Y% Revenue from Operations (in \u20b9 million) 20,321 19,635 16,585 22.5% 39,956 31,974 25.0% Steady state revenue 20,321 19,635 16,585 22.5% 39,956 31,974 25.0% Seasonal revenue (OE \/ AEP) - - - - - Revenue by Vertical split By Payer (in \u20b9 million) 18,262 17,585 14,682 24.4% 35,847 28,282 26.7% By Provider (in \u20b9 million) 2,059 2,050 1,903 8.2% 4,109 3,692 11.3% Reported YoY growth in revenue from operations (%) 22.5% 27.6% 25.2% 25.0% 25.5% Reported EBITDA (in \u20b9 million) 5,252 4,525 4,733 11.0% 9,776 8,293 17.9% Reported EBITDA % 25.8% 23.0% 28.5% 24.5% 25.9% Profit before exceptional items (in \u20b9 million) 3,742 3,026 3,268 14.5% 6,768 5,372 23.2% Profit before exceptional items margin % 18.4% 15.4% 19.7% 16.9% 16.8% Profit\/ (Loss) after tax (in \u20b9 million) 2,842 2,168 2,508 13.3% 5,010 3,994 25.4% Profit\/ (Loss) after tax margin % 14.0% 11.0% 15.1% 12.5% 12.5% Adjusted EBITDA (in \u20b9 million)* 5,353 4,716 4,352 23.0% 10,069 8,039 25.2% Adjusted EBITDA % 26.3% 24.0% 26.2% 25.2% 25.1% Adjusted PAT (in \u20b9 million)** 3,254 2,697 3,010 8.1% 5,951 5,007 18.9% Adjusted PAT % 16.0% 13.7% 18.1% 14.9% 15.7% Total Number of Employees 51,486 47,307 44,185 16.5% 51,486 44,185 16.5% Voluntary attrition rate^ 25.7% 28.6% 26.3% 26.6% 26.3% *Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI, BroadPath & CareSeed), share -based payment awards and excludes other income (including forex gain\/loss). **Adjusted PAT reflects EBITDA adjustments excluding other income and FX and adjustments for amortization of intangible assets arising from the carve -out of the healthcare business from HGS, as well as the statutory impact of increase in Minimum wages in Karnataka & Telangana, net of tax. ***Voluntary attrition is calculated for employees with tenure exceeding 90 days and presented on an annualized basis, derive d from voluntary exits during the quarter . Sagility Ltd. Press Release 4 Annual KPIs H1 FY27 FY26 FY25 FY24 FY23 Number of client groups* Active 105 82 75 44 35 Number of new client additions 28** 17 38 13 7 Delivery sites Number of delivery sites 28 31 33 30 27 New site addition (Gross) - 4 10 4 2 TTM Sep26 FY26 FY25 FY24 FY23 Client groups contribution to revenues^ Top 3 Client % 60.1% 59.9% 66.2% 68.3% 72.4% Top 5 Client % 70.3% 70.4% 77.9% 79.2% 80.6% Top 10 Client % 84.4% 83.9% 90.5% 91.4% 90.7% Number of Million-dollar client groups Number of clients contributing more than US$20 million 10 9 7 5 4 Number of clients contributing to US$5 - US$20 million 8 7 6 7 7 Number of clients contributing to US$1 - US$5 million 22 21 12 12 12 Number of clients contributing less than US$1 million 65 45 50 20 12 *Client groups comprise client entities together with their affiliates. ^Client group concentration represents the top clients based on trailing twelve -month revenue for the respective period. **30 clients added via CareSeed acquisition \u2013 26 new client groups, 2 common client groups and 2 affiliates of existing client groups .\"},{\"title\":\"Outcome of Board Meeting\",\"summary\":\"SAGILITY LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026.\",\"source\":\"NSE\",\"published\":\"22-Oct-2026 18:37:59\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026183617_IntimationResultsSigned.pdf\",\"disclosure_text\":\"Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 22, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C\/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir\/Ma\u2019am, Subject: Intimation of unaudited financial results for the quarter and half year ended September 30, 2026 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors of the Company, at its meeting held today, i.e., October 22, 2026, has, inter alia, approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026, together with the Limited Review Report issued by the Statutory Auditors. Copies of the aforesaid documents are enclosed herewith. The meeting commenced at 5:00 p.m. (IST) and concluded at 5:40 p.m. (IST). The above information is being made available on the website of the Company https:\/\/sagility.com\/ This is for your information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No. A16008 Encl: a\/a B S R & Co. LLP Chartered Accountants Embassy Golf Links Business Park Pebble Beach, B Block, 3rd Floor No. 13\/2, off Intermediate Ring Road Bengaluru - 560 071, India Telephone: +91 80 4682 3000 Fax: +91 80 4682 3999 Registered Office: B S R & Co. (a partnership firm with Registration No. BA61223) converted into B S R & Co. LLP (a Limited Liability Partnership with LLP Registration No. AAB-8181) with effect from October 14, 2013 14th Floor, Central B Wing and North C Wing, Nesco IT Park 4, Nesco Center, Western Express Highway, Goregaon (East), Mumbai - 400063 Page 1 of 4 Limited Review Report on unaudited consolidated financial results of Sagility Limited (formerly known as Sagility India Limited) for the quarter ended 30 September 2026 and year to date results for the period 1 April 2026 to 30 September 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Sagility Limited (formerly known as Sagility India Limited) 1. We have reviewed the accompanying Statement of unaudited consolidated financial results of Sagility Limited (formerly known as Sagility India Limited) (hereinafter referred to as \u201cthe Parent\u201d), and its subsidiaries (the Parent and its subsidiaries together referred to as \u201cthe Group\u201d) for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026 (\u201cthe Statement\u201d), being submitted by the Parent pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (\\\"Listing Regulations\\\"). 2. This Statement, which is the responsibility of the Parent\u2019s management and approved by the Parent\u2019s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 \u201c Interim Financial Reporting \u201d (\u201cInd AS 34\u201d), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 \u201cReview of Interim Financial Information Performed by the Independent Auditor of the Entity\u201d, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33(8) of the Listing Regulations, to the extent applicable. 4. The Statement includes the results of the entities mentioned in Annexure I. B S R & Co. LLP Limited Review Report (Continued) Sagility Limited (formerly known as Sagility India Limited) Page 2 of 4 5. Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For B S R & Co. LLP Chartered Accountants Firm\u2019s Registration No.:101248W\/W-100022 Hemanth Bhasin Partner Bangalore Membership No.: 235040 22 October 2026 UDIN:26235040ZMFONP6782 HEMANT Digitallysignedby HEMANTH BHASIN H BHASIN Date: 2026.10.22 18:00:09 +05'30' B S R & Co. LLP Limited Review Report (Continued) Sagility Limited (formerly known as Sagility India Limited) Page 3 of 4 Annexure I The consolidated financial results include the financial results of the Parent and entities listed below. Sr. No Legal name of the entity Relationship with the Parent 1 Sagility LLC Subsidiary 2 Sagility Provider Solutions LLC Subsidiary 3 Sagility Technologies LLC Subsidiary 4 Sagility Care Management LLC Subsidiary 5 Sagility Operations Inc. Subsidiary 6 Sagility (Jamaica) Limited Subsidiary 7 Sagility (US) Inc. Subsidiary 8 Sagility (US) Holdings Inc. Subsidiary 9 Sagility Philippines B.V. \u2013 Philippines Branch Branch of a subsidiary 10 Sagility Philippines B.V. Subsidiary 11 Sagility (Colombia) SAS Subsidiary 12 Sagility Payment Integrity Solutions LLC Subsidiary 13 Birch Technologies LLC Subsidiary 14 Sagility Member Enrollment LLC (formerly known as BroadPath LLC) Subsidiary 15 BroadPath Global LLC Subsidiary 16 Bhive Holdings LLC Subsidiary 17 BroadPath Global Services, Inc. Subsidiary 18 CareSeed LLC Subsidiary B S R & Co. LLP Limited Review Report (Continued) Sagility Limited (formerly known as Sagility India Limited) Page 4 of 4 (w.e.f. 11 June 2026) 19 Sagility ESOP Trust (w.e.f 7 July 2026) Controlled Trust Particulars Year ended 30 September 2026 30 June 2026 30 September 2025 30 September 2026 30 September 2025 31 March 2026 Unaudited Unaudited Unaudited Unaudited Unaudited Audited(refer note 3) 1 Income Revenue from operations 20,320.97 19,634.83 16,584.99 39,955.80 31,974.41 71,928.51 Other income 128.48 143.23 581.65 271.71 680.59 979.79 Total income 20,449.45 19,778.06 17,166.64 40,227.51 32,655.00 72,908.30 2 Expenses Employee benefits expense 12,294.40 12,275.91 10,270.19 24,570.31 20,142.29 45,102.76 Finance costs 185.39 218.92 249.92 404.31 524.00 991.62 Depreciation and amortisation expense 1,323.97 1,280.26 1,215.10 2,604.23 2,396.98 4,873.70 Other expenses 2,903.48 2,977.30 2,163.36 5,880.78 4,219.79 9,223.00 Total expenses 16,707.24 16,752.39 13,898.57 33,459.63 27,283.06 60,191.08 3 Profit before exceptional items and tax (1-2) 3,742.21 3,025.67 3,268.07 6,767.88 5,371.94 12,717.22 4 Exceptional items (refer note 8) - 150.89 - 150.89 - 328.23 5 Profit before tax for the period\/ year 3,742.21 2,874.78 3,268.07 6,616.99 5,371.94 12,388.99 6 Tax expense: Current tax 824.82 886.68 945.13 1,711.50 1,771.00 3,464.92 Deferred tax 75.27 (180.01) (185.32) (104.74) (392.91) (323.61) Total tax expense 900.09 706.67 759.81 1,606.76 1,378.09 3,141.31 7 Profit for the period\/ year 2,842.12 2,168.11 2,508.26 5,010.23 3,993.85 9,247.68 8 Other comprehensive income Items that will not be reclassified subsequently to profit or loss Re-measurement gains\/(losses) on defined benefit plans 16.46 (50.25) (87.53) (33.79) (89.23) (52.16) Income tax effect of the above (6.53) 5.51 23.78 (1.02) 13.48 28.20 Items that will be reclassified subsequently to profit or loss Exchange differences on translation of financial information of foreign operations 674.50 58.24 1,815.97 732.74 1,937.06 5,655.11 Change in fair value of derivatives designated as cash flow hedges (net) (A) (36.12) 542.06 (367.26) 505.94 (492.88) (1,820.85) Income tax effect on (A) above (21.86) (109.57) 62.71 (131.43) 77.15 284.10 Total other comprehensive income\/(loss) for the period\/ year, net of tax 626.45 445.99 1,447.67 1,072.44 1,445.58 4,094.40 9 Total comprehensive income for the period\/ year 3,468.57 2,614.10 3,955.93 6,082.67 5,439.43 13,342.08 10 Profit for the period\/ year attributable to: Owners of the Company 2,842.12 2,168.11 2,508.26 5,010.23 3,993.85 9,247.68 Non-controlling interests - - - - - - Profit for the period\/ year 2,842.12 2,168.11 2,508.26 5,010.23 3,993.85 9,247.68 11 Other comprehensive income\/(loss) for the period\/ year attributable to: Owners of the Company 626.45 445.99 1,447.67 1,072.44 1,445.58 4,094.40 Non-controlling interests - - - - - - Other comprehensive income for the period\/ year 626.45 445.99 1,447.67 1,072.44 1,445.58 4,094.40 12 Total comprehensive income for the period\/ year attributable to: Owners of the Company 3,468.57 2,614.10 3,955.93 6,082.67 5,439.43 13,342.08 Non-controlling interests - - - - - - Total comprehensive income for the period\/ year 3,468.57 2,614.10 3,955.93 6,082.67 5,439.43 13,342.08 13 Paid up equity share capital (face value of Rs. 10 each) 46,792.74 46,792.74 46,792.74 46,792.74 46,792.74 46,792.74 14 Other equity 49,798.23 15 Earnings per equity share (face value of Rs. 10 each) (Not annualised except for the year ended 31 March 2026 ) Basic (Rs) 0.61 0.46 0.53 1.07 0.85 1.98 Diluted (Rs) 0.61 0.46 0.53 1.07 0.85 1.98 (Page 1 of 4) Sagility Limited (formerly known as Sagility India Limited ) Corporate Identity Number: L72900KA2021PLC150054 Registered office: No.23 & 24 AMR Tech Park, Building 2A, First Floor, Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru Karnataka, 560 068, India. Telephone .: 91- 8071251500, E-mail: investorservices@sagility.com ; website: www.sagility.com Sr. No. Quarter ended Consolidated Financial Results for the quarter ended and six months ended 30 September 2026 (Rs. in millions unless otherwise stated) Six months ended ~sagility (Rs. in millions unless otherwise stated) Sr. No. As at 30 September 2026 (Unaudited) As at 31 March 2026 (Audited) (Refer note 3) A. ASSETS 1 Non-current assets Property, plant and equipment 4,602.56 4,231.22 Capital-work-in-progress 41.78 392.78 Right-of-use assets 4,249.63 4,867.68 Goodwill 66,085.39 64,051.49 Other intangible assets 20,219.13 20,370.15 Intangible assets under development 103.38 36.74 Financial assets Other financial assets 1,018.14 633.02 Deferred tax assets (net) 1,393.28 1,513.91 633.48 277.37 Other non-current assets 224.98 191.01 Total non-current assets 98,571.75 96,565.37 2 Current assets Financial assets Investments 3,994.46 3,358.70 Trade receivables 17,753.41 18,390.31 Cash and cash equivalents 5,323.12 3,579.16 Bank balances other than cash and cash equivalents 750.00 2,100.00 Other financial assets 338.87 353.86 Other current assets 1,851.13 1,663.38 Total current assets 30,010.99 29,445.41 Total assets 1,28,582.74 1,26,010.78 B. EQUITY AND LIABILITIES 1 EQUITY Equity share capital 46,792.74 46,792.74 Other equity Securities premium 50,523.72 50,523.72 Common control adjustment deficit account (28,186.58) (28,186.58) Other components of equity 33,151.13 27,461.09 Total equity 1,02,281.01 96,590.97 LIABILITIES 2 Non-current liabilities Financial liabilities Lease liabilities 3,192.83 3,811.12 Other financial liabilities 123.33 261.48 Provisions 2,359.79 2,161.13 Deferred tax liabilities (net) 4,148.86 4,211.07 Total non-current liabilities 9,824.81 10,444.80 3 Current liabilities Financial liabilities Borrowings 4,254.58 5,775.73 Lease liabilities 1,572.32 1,518.50 Trade payables Total outstanding dues of micro enterprises and small enterprises 168.28 242.65 Total outstanding dues of creditors other than micro enterprises and small enterprises 2,012.71 1,973.96 Other financial liabilities 5,887.04 7,273.99 Other current liabilities 740.81 586.10 Provisions 1,693.11 1,362.53 Current tax liabilities (net) 148.07 241.55 Total current liabilities 16,476.92 18,975.01 Total liabilities 26,301.73 29,419.81 Total equity and liabilities 1,28,582.74 1,26,010.78 (Page 2 of 4) Particulars Other tax assets (net) Sagility Limited (formerly known as Sagility India Limited ) Corporate Identity Number: L72900KA2021PLC150054 Registered office: No.23 & 24 AMR Tech Park, Building 2A, First Floor, Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru Karnataka, 560 068, India. Telephone .: 91- 8071251500, E-mail: investorservices@sagility.com ; website: www.sagility.com Consolidated Statement of Assets and Liabilities ~sagility\u00b7 (Rs. in millions unless otherwise stated) Particulars For the six months ended 30 September 2026 (Unaudited) For the six months ended 30 September 2025 (Unaudited) Cash flows from operating activities Profit before tax for the period 6,616.99 5,371.94 Adjustments: Depreciation and amortisation expense 2,604.23 2,396.98 Finance costs 404.31 524.00 Interest income (138.94) (96.98) - 0.55 Loss \/(gain) on sale\/ disposal of property, plant and equipment 45.58 (10.65) Expense relating to share based payment awards 75.50 144.60 Gain on investments measured through FVTPL (130.53) (15.45) Unrealised foreign exchange loss\/ (gain), net 109.39 (580.79) Operating profit before working capital changes 9,586.53 7,734.20 Working capital adjustments: Trade receivables 429.35 639.55 Non-current financial assets (368.48) (28.85) Other non-current assets 58.32 50.93 Current financial assets 37.12 (97.31) Other current assets (180.15) 72.07 Trade payables (40.43) (1,505.98) Provision for employee benefit obligations 484.44 276.07 Other current financial liabilities (1,520.70) 398.88 Other current liabilities 18.62 (114.06) Cash flows generated from operating activities 8,504.62 7,425.50 Income taxes paid (net of refunds) (2,161.54) (1,840.37) Net cash flows generated from operating activities (A) 6,343.08 5,585.13 Cash flows from investing activities (1,167.50) (809.54) Proceeds from sale of property, plant and equipment and other intangible assets 3.73 3.01 Payment for business combination, net of cash acquired Rs. 22.57 million (1,337.79) - Working capital adjustment on account of business combination - 42.53 Investments in fixed deposits (750.00) (600.00) Proceeds from maturity of fixed deposits 2,100.00 - Investments in mutual funds (7,440.00) (4,942.30) Proceeds from sale of mutual funds 6,933.10 2,521.47 Interest received 121.85 61.08 Net cash flows used in investing activities (B) (1,536.61) (3,723.75) Cash flows from financing activities Repayment of borrowings (1,495.42) (1,245.00) Repayment of lease liabilities (730.51) (681.84) (205.83) (229.61) Dividend paid (467.88) - Interest paid on borrowings (223.66) (314.38) Net cash flows used in financing activities (C) (3,123.30) (2,470.83) Net increase\/(decrease) in cash and cash equivalents (A+B+C) 1,683.17 (609.45) Cash and cash equivalents at the beginning of the year 3,579.16 3,437.58 Effects of movements in exchange rates on cash and cash equivalents 60.79 87.26 Cash and cash equivalents at the end of the period 5,323.12 2,915.39 Component of cash and cash equivalents Balances with banks - In current accounts 816.15 828.95 - In Exchange Earners Foreign Currency (\\\"EEFC\\\") accounts 25.73 21.28 - In Deposits with original maturity of less than three months 4,481.24 2,065.16 Total cash and cash equivalents at the end of the period 5,323.12 2,915.39 (Page 3 of 4) Provision for expected credit loss Acquisition of property, plant and equipment and other intangible assets Interest on repayment of lease liabilities Consolidated Statement of Cash Flows Sagility Limited (formerly known as Sagility India Limited ) Corporate Identity Number: L72900KA2021PLC150054 Registered office: No.23 & 24 AMR Tech Park, Building 2A, First Floor, Hongasandara Village, Off Hosur Road, Bommanahalli, Ben galuru Karnataka, 560 068, India. Telephone .: 91- 8071251500, E-mail: investorservices@sagility.com ; website: www.sagility.com ~sagility Notes to consolidated financial results for the quarter and six months ended 30 September 2026 1 2 3 4 5 6 7 8 9 10 Subsequent event : Place: Bengaluru for and on behalf of the Board of Directors Date: 22 October 2026 Ramesh Gopalan Managing Director and Group Chief Executive Officer (Page 4 of 4) In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the above consolidated financial results of Sagility Limited (\\\"the Holding Company\\\" or \\\"the Company\\\") and its subsidiaries (the Holding Company along with subsidiaries together referred to as \\\"the Group\\\") have been reviewed and recommended by the Audit Committee and approved by the Board of Directors, at their meetings held on 22 October 2026. These unaudited consolidated financial results have been subjected to limited review by \"},{\"title\":\"Investor Presentation\",\"summary\":\"Investor Presentation\",\"source\":\"NSE\",\"published\":\"22-Oct-2026 18:29:51\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026182936_IntimationInvestorPresentationsigned.pdf\",\"disclosure_text\":\"Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 22, 2026 To, The Manager Listing Department National Stock Exchange of India Limited (NSE) Exchange Plaza, 5th Floor Plot No. C\/1, G-Block Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 Symbol: SAGILITY To, The Manager Listing Department BSE Limited (BSE) Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001 Scrip Code:544282 Dear Sir\/Ma\u2019am, Subject: Submission of Investor Presentation to be made to investors on October 2 2, 202 6, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In continuation of our letter dated October 14, 2026, please find enclosed the investor presentation on the financial results of Sagility Limited for the quarter and half -year ended September 30, 2026. The presentation will be made to investors during the meeting scheduled for today, Thursday, October 22, 2026, at 7:30 p.m. (IST). The details are also being made available on the Company\u2019s website https:\/\/sagility.com\/ This is for your kind information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No: A16008 Encl: a\/a Investor Deck \u2013 Q2 FY27 Oct 22, 2026 Certain statements in this release concerning Sagility\u2019s future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any such statement that may have been made from time to time by or on behalf of the company. Safe Harbor \u25b6 11.9% Y-o-Y Constant currency organic growth in Q2 FY27, driven by expansion within national payers and mid market clients \u25b6 Won $40.2 M of ACV in Q2 FY27, from 31 existing clients and 1 new logo. Increasing traction seen in larger deals, supported by cross-sell and transformation-led opportunities \u25b6 Growing AI momentum with new SOW wins, production deployments driving client efficiencies, and AI-led GTM transformation enabling faster solutioning \u25b6 Acquired Chirok Health LLC to accelerate Provider segment growth. The acquisition adds specialized CDI and coding capabilities, extending Sagility\u2019s end-to-end RCM offering and unlocking new growth opportunities. Performance Highlights Revenue Adjusted EBITDA AdjustedPAT \u20b9 20,321 Million US$212.6M \u20b9 5,353 Million US $56.0M \u20b9 3,254 Million US$34.0M YoY growth % 22.5% 12.2% in CC Margin % 26.3% Margin % 16.0% YoY growth % (Excl. CareSeed) 22.2% YoY growth % 23.0% YoY growth % 8.1% Q2 FY27 Business Insights Rewards & Recognitions Sagility won the Golden Peacock Award for ESG Sagility\u2019s SmarTec Nurse Assist solution won 2026 Stratus Awards for Cloud Computing by Business Intelligence Group in SaaS category 11.9% in CC Revenue Adjusted EBITDA AdjustedPAT \u20b9 39,956 Million US$420.4M \u20b9 10,069 Million US $105.9M \u20b9 5,951 Million US$62.6M YoY growth % 25.0% 13.7% in CC Margin % 25.2% Margin % 14.9% YoY growth % (Excl. CareSeed) 24.7% YoY growth % 25.2% YoY growth % 18.9% H1 FY27 13.4% in CC Sagility India ranked 57 in 100 Best Large Workplaces in Asia 2026 by Great Place to Work\u00ae. Recognized amongst Top 10 India\u2019s Best Workplaces for Women 2026 Sagility India earns Great Place To Work\u00ae Certification for the second consecutive year Winner of Bronze Stevie\u00ae Award in the AI Adoption with Headcount Growth Leader in Avasant\u2019s Healthcare Payer Business Process Transformation 2026 RadarView Interim Dividend \u20b90.15 per share Received the Voice of the Customer Honor \u2013 HLS Services Specialist KPIs Note: *Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI , BroadPath & CareSeed), share-based payment awards and excludes other income (including forex gain\/loss). **Adjusted PAT reflects EBITDA adjustments excluding other income and FX and adjustments for amortization of intangible assets arising from the carve-out of the healthcare business from HGS, as well as the statutory impact of increase in Minimum wages in Karnataka & Telangana, net of tax ^Voluntary attrition is calculated for employees with tenure exceeding 90 days and presented on an annualized basis, derived from voluntary exits during the respective quarter Q2 FY27 Q1 FY27 Q2 FY26 YoY% H1 FY27 H1 FY26 YoY% Revenue from Operation (in \u20b9 M) 20,321 19,635 16,585 22.5% 39,956 31,974 25.0% Steady state Revenue 20,321 19,635 16,585 22.5% 39,956 31,974 25.0% Seasonal Revenue (Open Enrollment\/AEP) - - - - - - - Revenue by Vertical Split By Payer 89.9% 89.6% 88.5% 89.7% 88.4% By Provider 10.1% 10.4% 11.5% 10.3% 11.6% Growth in revenue from operation (%) 22.5% 27.6% 25.2% 25.0% 25.5% Adjusted EBITDA* (in \u20b9 M) 5,353 4,716 4,352 23.0% 10,069 8,039 25.2% Adjusted EBITDA % 26.3% 24.0% 26.2% 25.2% 25.1% Adjusted PAT** (in \u20b9 M) 3,254 2,697 3,010 8.1% 5,951 5,007 18.9% Adjusted PAT % 16.0% 13.7% 18.1% 14.9% 15.7% Total Number of Employees at the end of period 51,486 47,307 44,185 16.5% 51,486 44,185 16.5% Voluntary attrition rate^ (%) 25.7% 28.6% 26.3% 26.6% 26.3% Annual KPIs *Client groups comprise client entities together with their affiliates. **30 clients added via CareSeed acquisition \u2013 26 new client groups, 2 common client groups, 2 affiliates of existing client groups H1 FY27 FY26 FY25 FY24 FY23 Numbers of Client group Active 105 82 75 44 35 Number of new client addition (Gross) 28** 17 38 13 7 Delivery Sites Number of delivery sites 28 31 33 30 27 New site addition (Gross) - 4 10 4 2 TTM Sep26 FY26 FY25 FY24 FY23 Client groups contribution to revenues* Top 3 Client % 60.1% 59.9% 66.2% 68.3% 72.4% Top 5 Client % 70.3% 70.4% 77.9% 79.2% 80.6% Top 10 Client % 84.4% 83.9% 90.5% 91.4% 90.7% Number of Million-dollar client groups Number of clients contributing more than US$ 20M 10 9 7 5 4 Number of clients contributing to US$ 5M - US$ 20M 8 7 6 7 7 Number of clients contributing to US$ 1M - US$ 5M 22 21 12 12 12 Number of clients contributing less than US$ 1M 65 45 50 20 12 + Comprehensive end-to-end Provider RCM solution Chirok strengthens Sagility\u2019s provider footprint Founded in 2020 and headquartered in Nashville, Chirok Health is a specialized provider of Clinical Documentation Improvement (CDI) solutions. The company complements its core CDI offerings with adjacent solutions, including medical coding, RAC, and HEDIS\/Stars quality services. US$13 M TTM Sep 2026 revenue 35.8% TTM Sep 2026 Adjusted EBITDA margin 12+ 115%+ Net revenue retention\u00b9 750+ Employees US$20 M Upfront payment What Chirok adds to Sagility Mid-revenue Cycle expertise CHEMP Workflow platform Provider relationships Specialist talent Prospective, concurrent & retrospective CDI Coding & quality audits Review Validate Audit Provider queries Health systems Physician groups Risk-bearing providers 700+ operations staff Coding, QA & billing India & US delivery Unlocks synergies to broaden Sagility\u2019s provider offering and deliver greater client value Provider Clients (including large hospital systems) 1percentage of recurring revenue retained from existing customer base over a set period, including upgrades\/expansions while s ubtracting downgrades\/churn. Additionally, contingent consideration up to US$12.35 M payable subject to achievement of specified performance milestones Valuation Chirok bridges the CDI and coding gap, enabling Sagility to offer more comprehensive end-to-end provider revenue solutions Sagility Patient access Chirok core Clinical Documentation & coding Combined scope Billing & claims Sagility Clinical denials & appeals Sagility A\/R & collections Chirok rounds out Sagility clinical capabilities across providers and payers, enabling a more complete end-to-end offering. Growth opportunities Deepen provider relationships Health systems and physician groups Cross-sell patient access, denials and collections. Extend CDI and coding into additional specialties. Risk-bearing providers Pair accurate documentation and HCC capture with Sagility\u2019s care management, coordination and outreach. Payer Quality Health plans Combine chart review with HEDIS abstraction and care-gap closure. Support value-based care Marketing & Thought Leadership AI & Intelligent Operations Healthcare Perspectives Research & Insights SmarTec Solutions Advisor, Sasha CoreIQ Operational System of Intelligence Sagility Synchrony Provider Services Claims Lifecycle Case Studies HealthBridge Connect HealthBridge Connect SmarTec Voice Agent SmarTec Voice Agent Blogs CMS-0057-F Compliance CMS-0057-F Compliance Payment Accuracy Across the Claims Lifecycle Payment Accuracy Across the Claims Lifecycle White Paper Future-Proofing Healthcare Payer Operations with Intelligence\"},{\"title\":\"General Updates\",\"summary\":\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health\",\"source\":\"NSE\",\"published\":\"21-Oct-2026 21:20:50\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212037_IntimationChirokAcquisitionsigned.pdf\",\"disclosure_text\":\"Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 21, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C\/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir\/Madam, Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We wish to inform you that the Board of Directors of the Company at their meeting held on 21st October 2026, have proposed an acquisition\/investment by Sagility (US) Holdings Inc., a wholly owned subsidiary of Sagility Limited. Sagility (US) Holdings Inc., has signed a definitive agreement on 21 st October 2026, with Chirok Health LLC, the details of which are given as Annexure A to this letter, as required under the Listing Regulations read with SEBI Circular No. HO\/49\/14\/14(7)2025 -CFD- POD2\/I\/3762\/2026 dated January 30, 2026. Kindly take the above information on your record For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer Membership No: A16008 Place: Bengaluru Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Annexure A Details as required under SEBI Circular No. HO\/49\/14\/14(7)2025-CFD-POD2\/I\/3762\/2026 dated January 30, 2026 Sl. No. Particulars Details 1. Name of the target entity, details in brief such as size, turnover etc. Chirok Health LLC Turnover: US$ 9.0 M (CY2025) here hereafter mentioned as Chirok 2. Whether the acquisition would fall within related party transaction(s) and whether the promoter\/ promoter group\/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at \u201carm\u2019s length\u201d No 3 Industry to which the entity being acquired belongs. Healthcare services \/ Healthcare Revenue Cycle Management (RCM), including Clinical Documentation Integrity (CDI) and medical coding services. 4 Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity); The acquisition is intended to strengthen Sagility\u2019s capabilities in the provider segment by adding specialised Clinical Documentation Integrity (CDI), medical coding and revenue optimisation capabilities, complementing Sagility\u2019s existing healthcare servi ces portfolio. 5 Brief details of any governmental or regulatory approvals required for the acquisition NA 6 Indicative time-period for completion of the acquisition 21st October 2026 7 Consideration - whether cash consideration or share swap or any other form and details of the same Cash 8 Cost of acquisition and\/or the price at which the shares are acquired Aggregate purchase consideration of upto US$ 32.35 M, comprising: \u2022 Upfront payment of US$ 20.0 M at closing, subject to customary closing adjustments; and Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com \u2022 Contingent consideration upto US$ 12.35 M, payable subject to achievement of specified performance milestones 9 Percentage of shareholding \/ control acquired and \/ or number of shares acquired 100% 10 Brief background about the entity acquired in terms of products\/line of business acquired, date of incorporation, history of last 3 years\u2019 turnover, country in which the acquired entity has presence and any other significant information (in brief) Chirok Health LLC is a US -based healthcare services company providing Clinical Documentation Integrity (CDI), medical coding, Revenue Cycle Management (RCM), and audit and quality assurance services, supported by its proprietary CHEMP workflow platform. The Company was incorporated in 2019 and is headquartered in Tennessee, United States. The Company has turnover of approximately USD 12.7 M, USD 8.2 M, and USD 9.0 M for CY2023, CY2024, and CY2025 respectively.\"}],\"recent_news\":[{\"summary\":\"a press release dated October 22, 2026, titled \\\"Press release pertaining to unaudited financial results (standalone & consolidated) for the quarter ended September 30, 2026\\\".\",\"category\":\"Press Release\",\"date\":\"22-Oct-2026 18:44:34\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026184424_IntimationPressReleaseSigned.pdf\",\"headline\":\"Earnings \/ operating update\",\"impact\":\"Earnings updates are directly relevant to valuation. Revenue growth, margins, profit growth and management guidance are the key items to compare with expectations.\",\"importance_score\":5,\"completeness_score\":3},{\"summary\":\"SAGILITY LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026.\",\"category\":\"Outcome of Board Meeting\",\"date\":\"22-Oct-2026 18:37:59\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026183617_IntimationResultsSigned.pdf\",\"headline\":\"Earnings \/ operating update\",\"impact\":\"Earnings updates are directly relevant to valuation. Revenue growth, margins, profit growth and management guidance are the key items to compare with expectations.\",\"importance_score\":5,\"completeness_score\":3},{\"summary\":\"a press release dated October 21, 2026, titled \\\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health\\\".\",\"category\":\"Press Release\",\"date\":\"21-Oct-2026 21:25:15\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212509_IntimationPressReleasesigned.pdf\",\"headline\":\"Investment \/ acquisition update\",\"impact\":\"The transaction can affect growth strategy, capital allocation or market access. Investors should consider the size of the investment, ownership acquired and expected returns.\",\"importance_score\":4,\"completeness_score\":3},{\"summary\":\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health.\",\"category\":\"General Updates\",\"date\":\"21-Oct-2026 21:20:50\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212037_IntimationChirokAcquisitionsigned.pdf\",\"headline\":\"Investment \/ acquisition update\",\"impact\":\"The transaction can affect growth strategy, capital allocation or market access. Investors should consider the size of the investment, ownership acquired and expected returns.\",\"importance_score\":4,\"completeness_score\":3}],\"promoter_pledge\":{\"summary\":\"The promoter\/promoter-group disclosure states that the shares covered by the filing were free from encumbrance.\",\"events\":[{\"summary\":\"ge of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai \u2013 400 051 The Manager \u2013 DCS, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai \u2013 400001 Dear Sir(s), Sub.: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 I, SAGILITY B.V ., Promoter of the Sagility Limited (\u201cthe Company\u201d) on behalf itself and all other persons acting in concert with me, hereby declare and confirm that we have not made any encumbrance, directly or indirectly, other than those already disclosed during the financial year ended on 31st March, 2026 under Regulation 31 (4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Kindly take the same on record. Thanking You, For, Sagility B.V . ________________________________________ _____________________ Name: Vistra Management Services (Netherlands) B.V . Name: T. Bogaards Title: Director A (represented by T. Bogaards & Title: Director B W.E.G. Buijze as Proxyholder A & Proxyholder B, respectively) Docusign Envelope ID: 441B47B8-6A53-4E91-BA29-483410750176\",\"category\":\"Disclosure under SEBI Takeover Regulations\",\"date\":\"18-Jun-2026 17:25:38\",\"source\":\"NSE corporate filing\",\"attachment\":\"https:\/\/nsearchives.nseindia.com\/corporate\/team_sandeshc_16062026121542_29.pdf\",\"detail_level\":\"pdf_facts\"}],\"source\":\"NSE corporate filing\"},\"shareholding_snapshot\":{\"promoter_pct\":50.95,\"public_pct\":49.05,\"fii_pct\":10.38,\"dii_pct\":22.59,\"mf_pct\":15.13,\"institutional_pct\":32.97,\"noninst_pct\":16.08,\"mf_scheme_count\":33,\"pledged_shares\":null,\"pledged_pct_of_promoter\":null,\"mf_holders\":[{\"name\":\"ICICI Prudential Technology Fund\",\"shares\":158761940,\"pct\":3.39},{\"name\":\"Kotak Small Cap Fund\",\"shares\":86972029,\"pct\":1.86},{\"name\":\"Canara Robeco Mutual Fund A\/C Canara Robeco Small Cap Fund\",\"shares\":83285323,\"pct\":1.78},{\"name\":\"Axis Mutual Fund Trustee Limited A\/C Axis Mutual Fund A\/C Axis Small Cap Fund\",\"shares\":71407249,\"pct\":1.53}],\"period\":\"30-SEP-2026\",\"submission_date\":\"13-OCT-2026\",\"source\":\"NSE shareholding pattern XBRL\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1737173_13102026055925_WEB.xml\",\"previous_period\":\"30-JUN-2026\",\"previous_promoter_pct\":50.95,\"previous_fii_pct\":9.99,\"previous_dii_pct\":21.42,\"previous_mf_pct\":13.45,\"previous_institutional_pct\":31.41,\"previous_mf_scheme_count\":32,\"previous_pledged_pct_of_promoter\":null,\"previous_pledged_shares\":null}} --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sagility share price fell 2.67% to \u20b944.18 today. See why SAGILITY is falling, volume context, company developments and what to watch next.<\/p>\n","protected":false},"author":1,"featured_media":7521,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Sagility Share Price Today: Why SAGILITY Is Falling 2.67% | 23 October 2026","_witty_meta_description":"Sagility share price fell 2.67% to \u20b944.18 today. See why SAGILITY is falling, volume context, company developments and what to watch next.","_witty_primary_phrase":"Sagility share price today","_witty_reason_label":"profit-taking after recent gains amid sector weakness","_witty_reason_confidence":"medium","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[210],"class_list":["post-7522","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-movers","category-stocks-in-news","tag-sagility"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/7522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=7522"}],"version-history":[{"count":5,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/7522\/revisions"}],"predecessor-version":[{"id":8351,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/7522\/revisions\/8351"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media\/7521"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=7522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=7522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=7522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}